Logo image of PRLD

PRELUDE THERAPEUTICS INC (PRLD) Stock Analyst Ratings

NASDAQ:PRLD - Nasdaq - US74065P1012 - Common Stock - Currency: USD

0.9237  +0.04 (+4.59%)

After market: 0.9237 0 (0%)

Buy % Consensus

78

ChartMill assigns a Buy % Consensus number of 78% to PRLD. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 5.1. This target is 452.13% above the current price.
PRLD was analyzed by 9 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about PRLD.
In the previous month the buy percentage consensus was at a similar level.
PRLD was analyzed by 9 analysts. More opinions would make the average more meaningful.
PRLD Historical Analyst RatingsPRLD Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -54 -49 -44 -39 -34 -29 -24 -19 -14 -9 -4 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 0.921.014.595.1010.50 - 9.34% 396.91% 452.13% 1,036.73%
PRLD Current Analyst RatingPRLD Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades
Date Firm Action Rating
2025-05-05 HC Wainwright & Co. Reiterate Buy -> Buy
2025-04-29 JMP Securities Reiterate Market Outperform -> Market Outperform
2025-04-08 HC Wainwright & Co. Reiterate Buy -> Buy
2025-03-12 Citizens Capital Markets Reiterate Market Outperform -> Market Outperform
2024-12-11 JMP Securities Reiterate Market Outperform -> Market Outperform
2024-11-08 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-28 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-19 HC Wainwright & Co. Upgrade Neutral -> Buy
2024-09-16 JMP Securities Reiterate Market Outperform -> Market Outperform
2024-09-16 HC Wainwright & Co. Reiterate Neutral -> Neutral
2024-09-10 HC Wainwright & Co. Reiterate Neutral -> Neutral
2024-08-15 HC Wainwright & Co. Reiterate Neutral -> Neutral
2024-03-13 JMP Securities Initiate Market Outperform
2024-02-20 HC Wainwright & Co. Downgrade Buy -> Neutral
2023-12-19 Morgan Stanley Downgrade Equal-Weight -> Underweight
2023-11-07 HC Wainwright & Co. Maintains Buy -> Buy
2023-10-19 HC Wainwright & Co. Maintains Buy -> Buy
2023-08-17 HC Wainwright & Co. Reiterate Buy -> Buy
2023-08-04 Barclays Maintains Equal-Weight -> Equal-Weight
2023-08-04 Morgan Stanley Reiterate Equal-Weight -> Equal-Weight
2023-03-17 HC Wainwright & Co. Maintains Buy
2022-11-21 B of A Securities Downgrade Neutral -> Underperform
2022-11-17 HC Wainwright & Co. Maintains Buy
2022-11-15 Morgan Stanley Maintains Equal-Weight
2022-09-09 Morgan Stanley Downgrade Overweight -> Equal-Weight
2022-07-29 Jefferies Initiate Buy
2022-05-12 HC Wainwright & Co. Maintains Buy
2022-02-28 Barclays Downgrade Overweight -> Equal-Weight
2021-11-17 Barclays Maintains Overweight
2021-10-11 Morgan Stanley Upgrade Equal-Weight -> Overweight